Emapunil
| Title | Journal |
|---|---|
| Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders. | European archives of psychiatry and clinical neuroscience 20121101 |
| Translocator protein as a promising target for novel anxiolytics. | Current topics in medicinal chemistry 20120101 |
| Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold. | Journal of medicinal chemistry 20111027 |
| Synthesis and evaluation of novel carbon-11 labeled oxopurine analogues for positron emission tomography imaging of translocator protein (18 kDa) in peripheral organs. | Journal of medicinal chemistry 20110908 |
| In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110323 |
| Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain. | Synapse (New York, N.Y.) 20110301 |
| Imaging of peripheral-type benzodiazepine receptor in tumor: carbon ion irradiation reduced the uptake of a positron emission tomography ligand [11C]DAC in tumor. | Journal of radiation research 20100101 |
| Ultrafast LC method for purification and metabolite analysis of PET probes. | Nuclear medicine and biology 20100101 |
| Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat. | Synapse (New York, N.Y.) 20091101 |
| Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand. | Progress in neuro-psychopharmacology & biological psychiatry 20090831 |
| Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. | Science (New York, N.Y.) 20090724 |
| Quantitative analysis of peripheral benzodiazepine receptor in the human brain using PET with (11)C-AC-5216. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20090701 |
| [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain. | Bioorganic & medicinal chemistry letters 20090315 |
| Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice. | Pharmacology, biochemistry, and behavior 20080401 |
| In vitro and ex vivo autoradiography studies on peripheral-type benzodiazepine receptor binding using [11C]AC-5216 in normal and kainic acid-lesioned rats. | Neuroscience letters 20071127 |
| 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20071101 |
| Blood flow dependence of the intratumoral distribution of peripheral benzodiazepine receptor binding in intact mouse fibrosarcoma. | Nuclear medicine and biology 20061101 |
| Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. | British journal of pharmacology 20040801 |
| The pyruvate-dehydrogenase complex from Azotobacter vinelandii. 2. Regulation of the activity. | European journal of biochemistry 19751115 |